Home > Insider Trading > Filing (0001104659-23-094815)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1719406	Nrx Pharmaceuticals Inc.	NRXP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1303782	C Jonathan Javitt	C/O Nrx Pharmaceuticals Inc 1201 N. Market Street, Suite 111 Wilmington DE 19801	Chief Scientist	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-08-23	100,000	$0.33	446,332	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	12,599,997	Indirect	By the Jonathan Javitt Living Trust
Common Stock	1,422,000	Indirect	By the Javitt 2012 Irrevocable Dynasty Trust
Common Stock	300,000	Indirect	By the Jonathan Javitt Donor Advised Fund

Footnotes

Held by the Jonathan Javitt Living Trust of which the reporting person is the trustee of such trust.
Held by the Javitt 2012 Irrevocable Dynasty Trust of which the reporting person is the grantor of such trust. The reporting person is not a trustee or beneficiary of the Trust, and no beneficiary of the Trust resides in the reporting person's household. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Held by the Jonathan Javitt Donor Advised Fund of which the reporting person is the primary advisor of such fund.